FDA to Host Public Meeting on Drug Supply Chain Regulations

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to discuss the implementation of Title VII of the Food and Drug Administration Safety and Innovation Act, which aims to enhance the integrity of the drug supply chain, and to gather input on proposed regulations regarding imported drugs and commercial importers.